Sort   by:  
 Page size 
UnknownEfficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.
Not available
S-EPMC5559902 | biostudies-literature
UnknownMitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration.
Not available
S-EPMC8201929 | biostudies-literature
UnknownABCB10 exports mitochondrial biliverdin, driving metabolic maladaptation in obesity.
Not available
S-EPMC8300486 | biostudies-literature
UnknownCytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.
Not available
S-EPMC2674642 | biostudies-literature
UnknownEfficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Not available
S-EPMC5857389 | biostudies-literature
UnknownDevelopment and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals.
Not available
S-EPMC7161722 | biostudies-literature
UnknownBrain-wide neuronal circuit connectome of human glioblastoma.
Not available
S-EPMC12347542 | biostudies-literature
UnknownSingle-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Not available
S-EPMC8777199 | biostudies-literature
UnknownAdjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186 | biostudies-literature
UnknownThe predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Not available
S-EPMC8460445 | biostudies-literature
Sort   by:  
 Page size